Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Akebia, Amylyx, Beigene, Bristol Myers Squibb, Inhibrx, Iovance, Janssen, Lexicon, Metriopharm, SK, Valneva.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: A2, Abbisko, Algiax, Alterity, Alzecure, Aum, Consynance, Debiopharm, Dermbiont, Fore, Genprex, Hansa, Harbour, Immorna, Luzhu, Pfizer, Pyxis, Revive, Selection, Springworks, Theratechnologies.

Additional early-stage research and drug discovery news in brief, from: Amplia Therapeutics, Can-Fite Biopharma, Imunon, Lixte Biotechnology, Regcell.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Astrazeneca, Biophytis, BMS, Curium, Gilead, Hutchmed, Inventiva, Ipsen, Novavax, Novo Nordisk, Sino, Takeda.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Biophytis, Ferring, Genelux, Oxurion, Profoundbio, Structure, Theseus, TME, Xilio.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Accropeutics, Applied Therapeutics, Celltrion, Dyne, Hibio, Janssen, Legend, Pfizer, Sandoz.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Adamis, Biontech, DMK, Intercept, Madrigal, Pfizer.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Annexon, Antabio, Apellis, Bial, Bioinvent, Bioxcel, Harmony, Immutep, Jaguar, Lynk, Onconova, Stallergenes, Stemcyte, Topas, Transgene, Vanda.